Misplaced Pages

Cold-fX

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by 174.112.42.106 (talk) at 09:00, 22 January 2014 (→Medical uses: actual medicinal use and indication). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 09:00, 22 January 2014 by 174.112.42.106 (talk) (→Medical uses: actual medicinal use and indication)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
The topic of this article may not meet Misplaced Pages's notability guidelines for products and services. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.
Find sources: "Cold-fX" – news · newspapers · books · scholar · JSTOR (January 2014) (Learn how and when to remove this message)
The logo for the product

Cold-fX is a product derived from the roots of North American ginseng (Panax quinquefolius). Originally manufactured by Afexa Life Sciences Inc. (formerly called CV Technologies Inc.), headquartered in Edmonton, Alberta, Canada, the company and lead product was acquired by Valeant Pharmaceuticals International (headquartered in Laval, Quebec, Canada) in 2011.

It is approved for use to "help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system".

Medical uses

It is approved for use to "help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system"

Adverse effects

Individuals requiring anti-coagulant therapy such as warfarin should avoid use of COLD-FX. Not recommended for individuals with impaired liver or renal function. Do not exceed the recommended daily dose.

Individuals with known allergies to ginseng should avoid use of COLD-FX. Do not use if you are pregnant or breastfeeding.

Other adverse effects include: headaches, anxiety, trouble sleeping and an upset stomach.

Criticism

There is doubts in the medical and scientific community that Cold-fX is effective. All the studies posing 'significant' results favoring the efficacy of ColdFX have been funded by the manufacturer.

Other criticisms point out that these studies have been small scale, with conspicuously shallow participant pools and lopsided gender distributions. Researchers have pointed out that there aren't enough studies on the effects of any form of Ginseng on the common cold to form any conclusions.

Scientists have argued that Cold-fX has not been tested for its ability to treat a cold after an individual has been infected. In addition, no studies have yet been performed to assess the possible long term side effects of taking the pills every day during the cold and flu season. Afexa Life Sciences Inc. (formerly called CV Technologies Inc.), the makers of Cold-fX, were criticized for making health claims about the product that have never been tested or verified scientifically. Up until February 2007, the company advised a regimen of 18 pills over a course of 3 days in order to obtain "immediate relief" from a cold. Health Canada's review of the scientific literature confirmed that this is not a claim that CV Technologies Inc. is entitled to make. The company formulated a separate product for this usage. A CV Technologies press release explained the change in the dosing regimen as a choice to take a two-tier approach application to Health Canada.

References

  1. "What is COLD-fX intended for?". Cold-fX: Frequently Asked Questions. Retrieved 2007-11-24.
  2. http://webprod3.hc-sc.gc.ca/lnhpd-bdpsnh/info.do?lang=eng&licence=80002849
  3. Cite error: The named reference Nah2011 was invoked but never defined (see the help page).
  4. ^ Cite error: The named reference Seida2011 was invoked but never defined (see the help page).
  5. ^ "Fighting the Common Cold". ABC News. 2005-10-25.
  6. William Lin (2007-02-16). "Does ginseng really work? It depends on who you ask". The Ottawa Citizen.
  7. "Ginseng Unproven in U.S." Los Angeles Times. 2008-02-18.
  8. Charlie Gillis (2007-03-26). "COLD-fX catches the sniffles again". Macleans Magazine.
  9. "COLD-fX Sets Record Straight: Health Canada's Approval of New Medical Claims Unchanged" (PDF). CV Technologies. March 5, 2007.

External links

Category:
Cold-fX Add topic